Interesting about $abvx and $azn and their access to the data room? What exactly do they have access to though? I thought abivax will still be blinded to the data?

so our dear friend L is still banned. X went ahead and emailed him a few days ago, saying his account was restored but it actually isn't. our efforts are helping but please share this again one last time Nikita Bier #freehoundcl

Added a few more shares of $abvx for safety readout next week I expect good data with upcoming 100% of safety data by May and top maintenance data by end June Continue to believe that Obefazimod will be the new standard of care, best in class drug for UC, and CD in future

Perfect strategy …business as usual Don’t buy a company expecting a buyout…buy it for their asset VRNA story worked out perfectly after they hired a cco I expect a similar story here Looking forward for safety data on Monday …the rest is just noise

$abvx strategy

$abvx Management wants to wait for maintenance and crohns data to maximize shareholder value That’s my take So they will hire a cco and raise post data on very good numbers .build a company to sell the product, I think price will be much higher post maintenance and post crohns

Love the business updates on $abvx Hired cco, business as usual Obv maintenance data looks good if ceo is talking about a raise post data Abivax reminds me of Verona…get the drug to market followed by a buyout

Added to $abvx this week 100% safety data in April then looking forward to maintenance data in June Expecting Obefazimod to become best in class oral drug for UC considering black box warnings for current care Target $140 before data

Best in class and probably new standard of care in 2027 for UC $abvx

2026 could be big for Biopharma $XBI $IBB. Let’s see 🔮🤓

These constant buyout posts on $abvx are rather tiring Garidel will wait till maintence Cu in late june :)

Remains the only reason why we Love biotech Money always comes later

Was a nice dip to 120 in $abvx post $Syre data I think what people are missing on Abvx (apart from phase 3 ready oral drug) is that it can be combined with any other uc drug or works on its own Excited for upcoming June data, should confirm best in class and new standard of care

$eltx Intrigued here by the potential of the vaccine drug What’s interesting is that the company has not raised any money and their cash is only good till q3 26, so they must be confident in upcoming data in next 2 months Low float, low valuation, options call +ve

Tweet of the year?

Rezpeg slow drug acting so expect very strong data tomorrow on its way to 100

🐐

At 64 it’s free money here

9 abstracts $abvx Next soc in UC in 2027 Just waiting for 30% CR late June

☕️☕️